Gamaleya Research Institute Of Epidemiology And Microbiology
- All
- News
-
Russia's Sputnik V Vaccine Effective Against Delta, Other Covid Variants: Study
The Gamaleya National Research Center of Epidemiology and Microbiology and RDIF on Monday announced strong results of the study on neutralizing the activity of sera from individuals vaccinated with Sputnik V vaccine against new coronavirus variants.
-
Russia Looking For Partnership With India For Producing COVID-19 Vaccine: Official
Russia is looking for a partnership with India for producing COVID-19 vaccine Sputnik V, Kirill Dmitriev, the CEO of the Russian Direct Investment Fund (RDIF), said on Thursday.
-
Russia's Sputnik V Vaccine Effective Against Delta, Other Covid Variants: Study
The Gamaleya National Research Center of Epidemiology and Microbiology and RDIF on Monday announced strong results of the study on neutralizing the activity of sera from individuals vaccinated with Sputnik V vaccine against new coronavirus variants.
-
Russia Looking For Partnership With India For Producing COVID-19 Vaccine: Official
Russia is looking for a partnership with India for producing COVID-19 vaccine Sputnik V, Kirill Dmitriev, the CEO of the Russian Direct Investment Fund (RDIF), said on Thursday.
